Novartis suspends some business activities in Russia
The move by Novartis follows similar steps by other drugmakers following sanctions against Moscow for its invasion of Ukraine
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Parliamentary panel for framing price control regime for COVID medicines medical devices
The panel also recommended exemption of basic customs duty and GST on medicines and medical devices for fighting COVID-19
Evotec receives €3 million payment for Bayer starting phase-II clinical development of DNP programme
The phase-II study is anticipated to run until the end of 2022
Sun Pharma to acquire 11.28 per cent stake in Zenotech from Daiichi Sankyo
Sun Pharma said it will pay Rs 5.32 crores for the stake
Pfizer’s antiviral COVID drug still effective despite resistance fear
Researchers from the Rutgers University in the US showed that the Pfizer antiviral drug Paxlovid still quashes COVID by jamming…
Copper Histidinate data to be presented at 2022 American College of Medical Genetics Annual Clinical…
The previously reported results are from an efficacy and safety analysis of data integrated from two completed pivotal studies in…
Lonza signs manufacturing agreement with Oasmia for ovarian cancer drug
Under the agreement, Lonza will provide kilogram-scale synthesis, purification and stability testing of Cantrixil, and deliver…
Alembic Pharma receives US FDA final approval for Lacosamide tablets
Lacosamide tablets are indicated for the treatment of partial-onset seizures in patients four years of age and older
AstraZeneca COVID drug neutralises Omicron sub-variants in lab study
This is the first data looking at the impact of AstraZeneca's Evusheld treatment on "cousins" of the Omicron variant following a…
Hetero receives CDSCO approval to manufacture Sputnik Light vaccine for sale in India
Hetero is the first biopharma company in India to receive Manufacturing and Marketing (M&M) approval for the product…
Glenmark Pharma receives ANDA approval for Lacosamide tablets
The company plans to launch the product immediately
Second Covishield dose can be given between eight to16 weeks after first dose: NTAGI
Currently, the second dose of Covishield is given between 12-16 weeks after the first dose under the National COVID-19 Vaccination…
US FDA approves new Bristol Myers cancer immunotherapy
The company said it expects the treatment to eventually garner annual sales of more than $4 billion
US FDA approves Marinus Pharma’s lead drug to treat genetic disorder
The oral drug, which will be sold under the brand name Ztalmy, is intended specifically for treatment of seizures associated with…
Biolexis to collaborate with Akston Biosciences for COVID-19 vaccine
In a joint statement, the two companies said they will collaborate for the production and sales of Akston's AKS-452, a protein…
Zydus receives PAS approval from US FDA for Mycophenolate Mofetil for injection
The injection will be manufactured at the group’s injectables manufacturing facility at Jarod near Vadodara in Gujarat
MSF responds to potential compromise to ‘TRIPS Waiver’
Compromise neglects COVID-19 treatments and diagnostics and fails to address Intellectual Property (IP) barriers beyond patents,…
35 generic manufacturers sign agreements with MPP to produce generic versions of Pfizer’s…
The sublicence agreements are the result of the voluntary licensing agreement signed by MPP and Pfizer in November 2021 that will…
Fibroheal raises debt funding from BIRAC
The company intends to scale up its go-to-market capabilities, recruit more people on board and create an impact through the…
CCI approves acquisition of Micro Life Sciences by South Elm Investments BV
The proposed combination pertains to the proposed acquisition of minority stake in Micro Life Sciences (Micro Life/Target) by…